The Society for Immunotherapy of Cancer (SITC)
Fortrea is proud to participate in the 40th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer (SITC)—a premier gathering of global experts advancing the science and application of cancer immunotherapy.
As a leading clinical research organization with speciality in oncology and immuno-oncology, Fortrea will be on-site to share insights, showcase capabilities, and connect with innovators driving the next wave of therapeutic breakthroughs.
What to Expect from Fortrea at SITC:
- Expert Insights: Meet our oncology and immunotherapy specialists to discuss trial design, regulatory strategy, and operational excellence in Immuno-Oncology studies.
- Thought Leadership in Immuno-Oncology: While Fortrea is not presenting featured research at SITC 2025, we invite you to explore our growing portfolio of peer-reviewed publications that reflect our commitment to advancing immunotherapy and precision oncology. These publications highlight our work in clinical trial design, biomarker integration, and operational innovation across a range of oncology indications. Explore Fortrea’s Oncology Publications
- Partnering Opportunities: Learn how Fortrea collaborates with biotech innovators, academic centers, and sponsors to accelerate immuno-oncology breakthroughs.
Visit Us at Booth #721
Stop by our exhibit space to speak with Fortrea specialist, explore collaboration opportunities, and discover how we’re enabling the future of personalized cancer care.
Fortrea supports the full lifecycle of immunotherapy development—from early-phase strategy and biomarker integration to global trial execution and regulatory navigation. Our oncology teams work closely with sponsors and sites to overcome operational barriers and bring transformative therapies to patients faster.
Let’s connect at SITC 2025.
